Posted On: 08/27/2014 2:30:16 PM
Post# of 30066
My favorite news today
Wolfram syndrome (Diabetes) two-step strategy to stop the progression, stem cell technology and MANF -Dr Urano
Early revenue guidance for LymPro (On the conference call) -GC
Phase 2b initiation with Eltoprazine for PD LID
First-in-man trial for MANF in orphan ophthalmological indications (RP)
Up listing on a national exchange in the near future
Retirement of significant derivative liability- Robert Farrell
Cash equivalents totaling approximately $2.4 million (Plus Lincoln Park 20 million)
Wolfram syndrome (Diabetes) two-step strategy to stop the progression, stem cell technology and MANF -Dr Urano
Early revenue guidance for LymPro (On the conference call) -GC
Phase 2b initiation with Eltoprazine for PD LID
First-in-man trial for MANF in orphan ophthalmological indications (RP)
Up listing on a national exchange in the near future
Retirement of significant derivative liability- Robert Farrell
Cash equivalents totaling approximately $2.4 million (Plus Lincoln Park 20 million)
(0)
(0)
